Paul Dale has over 25 years of experience in the medical technology and biopharmaceutical industries spanning local and global roles across pricing, reimbursement, market access, consulting and commercialisation. For the past 7 years he has been Director of Policy at the Medical Technology Association of Australia (MTAA), responsible for policy development for the industry in device reimbursement and digital health. From 2019 to 2023, Paul was MTAA’s representative on the Prostheses List Advisory Committee providing advice to the Commonwealth Department of Health on listing of devices on the Prostheses List (now Prescribed List). Paul has a degree in Public Policy.